Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ZLDPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 66.43M
March 31, 2026 -0.1566M
December 31, 2025 -2.864M
September 30, 2025 12.82M
June 30, 2025 46.34M
March 31, 2025 -0.5001M
December 31, 2024 33.60M
September 30, 2024 39.47M
June 30, 2024 -973.77M
March 31, 2024 -211.89M
December 31, 2023 -2.052M
September 30, 2023 -0.9802M
June 30, 2023 -203.99M
March 31, 2023 -4.781M
December 31, 2022 -105.51M
September 30, 2022 -0.1591M
June 30, 2022 -38.19M
March 31, 2022 0.00
December 31, 2021 2.602M
September 30, 2021 6.330M
June 30, 2021 -2.030M
March 31, 2021 -114.41M
December 31, 2020 0.1461M
September 30, 2020 -0.8701M
June 30, 2020 -94.21M
Date Value
March 31, 2020 -21.75M
December 31, 2019 -3.366M
September 30, 2019 -82.52M
June 30, 2019 -2.316M
March 31, 2019 -13.87M
December 31, 2018 -0.3233M
September 30, 2018 -0.1167M
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 -2.028M
September 30, 2017 -78.76M
June 30, 2017 -0.4577M
March 31, 2017 -0.1174M
December 31, 2016 -20.42M
September 30, 2016 -0.5363M
June 30, 2016 -1.318M
March 31, 2016 -0.5766M
December 31, 2015 -3.494M
September 30, 2015 -7.095M
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Genmab A/S -1.255M
Ascendis Pharma A/S 38.47M
Bavarian Nordic A/S 34.93M
Evaxion AS 0.00
ACADIA Pharmaceuticals, Inc. -10.49M